The wait for the Covid-19 vaccine may be longer for the young population in good health, said World Health Organization chief scientist Dr. Soumya Swaminathan at a WHO social media event. . “Most people agree, it’s starting with healthcare workers and front-line workers, but even there, you need to define …
Read More »India expects to vaccinate 20-25 million million people by July next year
By: Desk Explained | Pune | Updated: October 6, 2020 9:21:50 am Travelers wearing masks wait at a traffic intersection in Kochi, Kerala (AP) Coronavirus Vaccine Tracker: India is working to vaccinate 20 to 25 million million of its population, about one sixth of its total population, against Covid19 disease …
Read More »Covid-19: how nasal, single injection and passive vaccines work
In the ongoing race for an effective Covid-19 vaccine, several pharmaceutical companies are exploring out of the ordinary places. Johnson & Johnson is testing a single-shot vaccine, while traditional vaccine candidates require two injections. Bharat Biotech has announced the manufacture of an intranasal vaccine, which will differentiate it from intramuscular …
Read More »Covid-19 Vaccine: When Will the U.S. Get Its First Vaccine? – world News
When Johnson & Johnson announced the third phase of its Covid-19 vaccine clinical trial, US President Donald Trump said that four Covid-19 vaccine candidates are in the final stage. Here is the status of the ongoing trials Pfizer The candidate vaccine being developed by Pfizer and its German partner BioNTech …
Read More »1.2 billion doses of Russian vaccine reserved
By: Desk Explained | Pune | Updated: September 22, 2020 9:16:23 am Moscow: An injection of Russia’s experimental Sputnik V coronavirus vaccine is shown before use in Moscow, Russia (AP) Coronavirus Vaccine Tracker: At least ten countries in Asia, South America and the Middle East have signed agreements to access …
Read More »Serum Institute to resume Covid-19 vaccine trial after DGCI gives its go-ahead
After pharmaceutical company AstraZeneca announced the resumption of its Covid-19 vaccine trial in the UK, its partner at India Serum Institute said it will also restart trials once the General Medicines Controller of India (DGCI) gives its okay. The DGCI previously sent a show of cause notice to the Pune-based …
Read More »The US and UK open the possibility of an opportunity this year
By: Desk Explained | Updated: August 31, 2020 10:00:05 am US President Donald Trump gestures during a tour of a pharmaceutical manufacturing plant where components are being developed for a possible vaccine candidate for the coronavirus disease (COVID-19), in North Carolina (Reuters / Archive) Coronavirus Vaccine Tracker (COVID-19): Raising the …
Read More »